| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/10/2000 | WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | WO2000006205A1 Regulated expression of recombinant proteins using rna viruses |
| 02/10/2000 | WO2000006204A2 Genetically engineered cells and tissues |
| 02/10/2000 | WO2000006203A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 02/10/2000 | WO2000006199A1 Kvlqt1 - a long qt syndrome gene |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006189A2 Conversion of naturally-occurring quinones to quinone derivatives by macrophage migration inhibition factor and uses thereof |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT |
| 02/10/2000 | WO2000006120A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | WO1999064566A8 In vitro maintenance of hematopoietic stem cells |
| 02/10/2000 | WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 02/10/2000 | WO1999061067B1 Gene expression method |
| 02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2338001A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | CA2337692A1 Kdel receptor inhibitors |
| 02/10/2000 | CA2337496A1 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | CA2337102A1 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336543A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | CA2336536A1 Growth differentiation factor-11 |
| 02/10/2000 | CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | CA2336263A1 Kvlqt1 - a long qt syndrome |
| 02/10/2000 | CA2335643A1 C7f2-a novel potassium channel .beta.-subunit |
| 02/10/2000 | CA2335228A1 Human epidermal proteins hepi-1 to hepi-6 |
| 02/09/2000 | EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression |
| 02/09/2000 | EP0977993A1 Cadherin-11 as an indicator of viable pregnancy |
| 02/09/2000 | EP0977881A1 Expression of a modified foamy virus envelope protein |
| 02/09/2000 | EP0977880A2 Materials and methods for treatment of retinal diseases |
| 02/09/2000 | EP0977879A2 Eukaryotic gene expression cassette and uses thereof |
| 02/09/2000 | EP0977871A1 Neurotrypsin |
| 02/09/2000 | EP0977862A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/09/2000 | EP0977855A2 Polypeptides associated with activator receptors and their biological applications |
| 02/09/2000 | EP0977854A2 Truncated vegf-related proteins |
| 02/09/2000 | EP0977849A1 Leukemia associated genes |
| 02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 02/09/2000 | EP0977841A2 Materials and methods for ribozyme treatment of retinal diseases |
| 02/09/2000 | EP0977777A1 A novel th2-specific gene |
| 02/09/2000 | EP0977771A1 Sequence alterations using homologous recombination |
| 02/09/2000 | EP0977596A1 Use of papovavirus capsid protein for delivery of genetic material |
| 02/09/2000 | EP0977595A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | EP0977585A1 Methods for diagnosing and treating body weight related disorders in animals |
| 02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | CN1244215A Improved method for the production and purification of adenoviral vectors |
| 02/09/2000 | CN1244213A Pressure-mediated intracellular delivery of molecules or microparticles |
| 02/09/2000 | CN1243751A Method for induction of immunity against virus |
| 02/08/2000 | US6022962 Hairpin ribozymes |
| 02/08/2000 | US6022874 Piperazine based cytofectins |
| 02/08/2000 | US6022864 Nucleic acid respiratory syncytial virus vaccines |
| 02/08/2000 | US6022863 Gene promoter suppressing nucleic acids which suppress transcription from a promoter of interest. |
| 02/08/2000 | US6022855 Novel variants of the naturally-occurring protease inhibitor, alpha1-antitrypsin and derived peptides comprising a sequence of-arg-xaa-xaa-arg-; viricides; bactericides; blocking of endoproteolytic activation of a bacterial toxin |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022738 Vectors for expression of globin genes |
| 02/08/2000 | US6022737 Formulations for non-viral in vivo transfection in the lungs |
| 02/08/2000 | US6022736 Nucleic acid vectors comprising DNase I hypersensitive sites |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential |
| 02/08/2000 | US6022687 Diagnosis of and therapy for hereditary haemorrhagic telangiectasia |
| 02/03/2000 | WO2000005407A2 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 02/03/2000 | WO2000005394A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 02/03/2000 | WO2000005393A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005359A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | WO2000005356A1 Methods and compositions for inhibition of angiogenesis |
| 02/03/2000 | WO2000005348A1 Pneumococcal nrdg protein |
| 02/03/2000 | WO2000005343A2 Cell expansion system for use in neural transplantation |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000004928A1 Gene therapy method for revascularizing ischemic tissue |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004876A2 Controlled release of bioactive substances |
| 02/03/2000 | WO1999061628A3 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/03/2000 | WO1999060108A3 Transgenic animals produced by homologous sequence targeting |
| 02/03/2000 | WO1999054459A8 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/03/2000 | WO1999051263A3 Methods and modified cells for the treatment of cancer |
| 02/03/2000 | WO1999047638A3 Mutations in mitotic check point genes and methods of diagnosis |
| 02/03/2000 | DE19834430A1 Selbstdeletierende Vektoren für die Krebstherapie Selbstdeletierende vectors for cancer therapy |
| 02/03/2000 | CA2336595A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/02/2000 | EP0975810A1 Method of pcr testing of pooled blood samples |
| 02/02/2000 | EP0975786A2 Novel transgene expression system for increased persistence |
| 02/02/2000 | EP0975785A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |